• Offer E Edelstein, Oren Wacht, Richard Isralowitz, Alexander Reznik, and Yaacov G Bachner.
• Ben-Gurion University of the Negev, The Spitzer Department of Social Work, Beer-Sheva, 841050, Israel. Electronic address: offere@bgu.ac.il.
• Complement Ther Med. 2020 Aug 1; 52: 102418.

AimsThe aims of the current study were as follows: 1) to assess gerontology graduate students' beliefs about medical marijuana's (MMJ) effectiveness for two common age-related conditions - Alzheimer's (AD) and Parkinson's disease (PD); 2) to assess students' beliefs and attitudes toward MMJ; 3) to explore associations linking background characteristics, MMJ-related attitudes and beliefs, and beliefs about the MMJ effectiveness for AD and PD.MethodA sample of 104 (84 women and 20 men) gerontology graduate students voluntarily participated in the anonymous online survey.ResultsThe vast majority (95%) of the participants indicated they had no formal education about MMJ and reported being unprepared to answer clients' MMJ-related questions (84.6%). Most of the participants believed that MMJ is effective for use with AD (70.2%) and PD (80.8%) patients. Participants reported favorable beliefs about MMJ benefits, concerns about risks, the need for training, and positive attitudes toward recreational marijuana use legalization. Prior marijuana use (e.g., self-use, friends or family) was found to be associated with more positive beliefs about MMJ benefits, risks, and its legalization for recreational purposes. Prior marijuana use was the only factor associated with the belief that MMJ is an effective therapy for use with AD or PD patients.ConclusionsThe study findings show the need for students' MMJ education in order to provide future gerontology service providers with the necessary knowledge and ability to address clients' questions about MMJ use. Efforts to develop curricula and training programs need to be promoted.Copyright © 2020 Elsevier Ltd. All rights reserved.

24 keywords...

hide…